Articles related to CANNABIS USE DISORDERS

Cannabis use at psychiatric admission was associated with a higher risk of early rehospitalization among young adults hospitalized for bipolar or psychotic disorders, although the association weakened over time and was no longer statistically significant by six months.

A meta-analysis of seven studies found cannabinoid-based therapies were associated with lower agitation and neuropsychiatric symptom scores in patients with moderate to severe Alzheimer disease. Cognitive benefits were not consistently observed, and somnolence occurred more frequently with treatment.

A randomized crossover trial of 108 habitual cannabis users found fewer premature atrial contractions on cannabis-use days than abstinence days. The short-term physiologic findings provide mechanistic insight but were not designed to evaluate long-term cardiovascular health outcomes.

A narrative review and accompanying expert commentary outlined diagnostic features distinguishing substance-induced psychosis from primary psychotic disorders amid rising cannabis and stimulant exposure.

As cannabis becomes more widely available and socially accepted and legalized in various jurisdictions, it is essential to understand its potential health risks and the need for health care professionals to routinely talk to patients about cannabis use.

Reclassifying marijuana from Schedule I to a lower schedule would significantly ease the regulatory burden on researchers.